We are Sorry, This Page doesn't Exist

Walmart raised its earnings forecast ahead of the holiday shopping season. And as Fred Katayama reports, it reopened its El Paso, Texas store that was the site of a massacre that killed 22 people......»»

AbbVie (NYSE: ABBV) reported third-quarter earnings of $2.33 per share on Friday, which beat the analyst consensus estimate of $2.30 by 1.3%.....»»

AbbVie (NYSE: ABBV) reported third-quarter earnings of $2.33 per share on Friday, which beat the analyst consensus estimate of $2.30 by 1.3%. This is a 8.88% increase over earnings of $2.14 per share from the same period last year. read more.....»»

Zacks.....»»

It has been about a mon.....»»

AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2019 Results - Earnings Call Transcript.....»»

AbbVie (NYSE: ABBV) reported second-quarter earnings of $2.26 per share, which beat the analyst consensus estimate of $2.20. This is a 13% increase over earnings of $2 per share from the same period last year. read more.....»»

Continued weakness within the cloud and service provider verticals, and decline in average selling price are likely to take a heavy toll on Juniper's (JNPR) Q.....»»

While Crown Castle International's (CCI) site-rental revenues will likely improve, intense competition amid growth potential of the tower sector might dent net revenues from networ.....»»

Avianca Holdings' (AVH) top line is likely to gain from robust passenger revenues in first-quarter 2019. .....»»

Avianca Holdings' (AVH) top line is likely to gain from robust passenger revenues in first-quarter 2019. .....»»

On Axsome's (AXSM) first-quarter earnings call, investors will look for its progress with the CNS pipeline candidates and the regulatory updates on the sam.....»»

Western Union's (WU) Q1 results are likely to reflect lower revenues, cost savings from its restructuring initiatives and adverse affect of f.....»»

Unfavorable spread differential will likely escalate Two Harbors Investment's (TWO) cost of funds. Further, dismal U.S. housing activity might result in muted growth in its RMBS portfolio .....»»

The current Zacks Consensus Estimate for Royal Dutch Shell's (RDS.A) Q1 EPS is pegged at $1.05 pe.....»»

Cigna's (CI) Q1 earnings should benefit fr.....»»

Cognizant's (CTSH) first-quarter 2019 results are likely to benefit from domain expertise and acquisitions that are adding new custome.....»»

Macerich's (MAC) efforts to enhance its asset quality will enable it to grab attention from new and productive tenants, and witness higher mall traffic .....»»

Zacks.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»